521 related articles for article (PubMed ID: 18577894)
21. Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma.
Jassem J; Ramlau R; Santoro A; Schuette W; Chemaissani A; Hong S; Blatter J; Adachi S; Hanauske A; Manegold C
J Clin Oncol; 2008 Apr; 26(10):1698-704. PubMed ID: 18375898
[TBL] [Abstract][Full Text] [Related]
22. [Malignant pleural mesothelioma in 1997].
Viallat JR; Boutin C; Kasseyet S
Schweiz Med Wochenschr; 1997 Oct; 127(41):1707-11. PubMed ID: 9441378
[TBL] [Abstract][Full Text] [Related]
23. Multimodality treatment of malignant pleural mesothelioma with or without immunotherapy: does it change anything?
Lucchi M; Picchi A; Alí G; Chella A; Guglielmi G; Cristaudo A; Fontanini G; Mussi A
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):572-6. PubMed ID: 20053697
[TBL] [Abstract][Full Text] [Related]
24. Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
Opitz I; Lardinois D; Arni S; Hillinger S; Vogt P; Odermatt B; Rousson V; Weder W
Eur J Cardiothorac Surg; 2007 May; 31(5):773-8. PubMed ID: 17350855
[TBL] [Abstract][Full Text] [Related]
25. Life after first-line chemotherapy in malignant pleural mesothelioma: a North-East England experience.
Steer J; Bough G; Razak AR; Meachery GJ; Hughes A
Clin Oncol (R Coll Radiol); 2010 Apr; 22(3):231-5. PubMed ID: 20346340
[TBL] [Abstract][Full Text] [Related]
26. [Malignant pleural mesothelioma].
Kawamata O; Kondu Y; Murata T; Uetsuka H; Uda M; Nakai H; Ohta T
Kyobu Geka; 2007 Jan; 60(1):31-4. PubMed ID: 17249535
[TBL] [Abstract][Full Text] [Related]
27. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
[TBL] [Abstract][Full Text] [Related]
28. Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma.
Xia H; Karasawa K; Hanyu N; Chang TC; Okamoto M; Kiguchi Y; Kawakami M; Itazawa T
Int J Hyperthermia; 2006 Nov; 22(7):613-21. PubMed ID: 17079218
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic options in malignant pleural mesothelioma].
Serke M; Loddenkemper R
Pneumologie; 2005 May; 59(5):337-48. PubMed ID: 15902599
[TBL] [Abstract][Full Text] [Related]
30. Cold-plasma coagulation in the treatment of malignant pleural mesothelioma: results of a combined approach.
Hoffmann M; Bruch HP; Kujath P; Limmer S
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):502-5. PubMed ID: 20075037
[TBL] [Abstract][Full Text] [Related]
31. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma.
Halstead JC; Lim E; Venkateswaran RM; Charman SC; Goddard M; Ritchie AJ
Eur J Surg Oncol; 2005 Apr; 31(3):314-20. PubMed ID: 15780570
[TBL] [Abstract][Full Text] [Related]
32. Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series.
Aelony Y; Yao JF
Respirology; 2005 Nov; 10(5):649-55. PubMed ID: 16268920
[TBL] [Abstract][Full Text] [Related]
33. Intrathoracic chemo-thermotherapy with radiofrequency waves after extrapleural pneumonectomy for malignant pleural mesothelioma.
Tokunaga T; Higashiyama M; Okami J; Maeda J; Fujiwara A; Kodama K
Interact Cardiovasc Thorac Surg; 2011 Sep; 13(3):267-70. PubMed ID: 21680551
[TBL] [Abstract][Full Text] [Related]
34. Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
Aigner C; Hoda MA; Lang G; Taghavi S; Marta G; Klepetko W
Eur J Cardiothorac Surg; 2008 Jul; 34(1):204-7. PubMed ID: 18407510
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors for 100 patients with malignant pleural mesothelioma.
Gonlugur U; Gonlugur TE
Arch Environ Occup Health; 2010; 65(2):65-9. PubMed ID: 20439224
[TBL] [Abstract][Full Text] [Related]
36. A retrospective analysis of malignant pleural mesothelioma patients treated either with chemotherapy or best supportive care between 1990 and 2005 A single institution experience.
Metintas M; Ak G; Erginel S; Alatas F; Yildirim H; Kurt E; Metintas S
Lung Cancer; 2007 Mar; 55(3):379-87. PubMed ID: 17174436
[TBL] [Abstract][Full Text] [Related]
37. [Chemotherapy of malignant pleural mesothelioma: have we made any progress?].
Reck M; Heigener DF; Gatzemeier U
Zentralbl Chir; 2008 Jun; 133(3):238-42. PubMed ID: 18563688
[TBL] [Abstract][Full Text] [Related]
38. Phase-contrast microscopy studies of early cisplatin-induced morphological changes of malignant mesothelioma cells and the correspondence to induced apoptosis.
Janson V; Behnam-Motlagh P; Henriksson R; Hörstedt P; Engström KG; Grankvist K
Exp Lung Res; 2008 Feb; 34(2):49-67. PubMed ID: 18266129
[TBL] [Abstract][Full Text] [Related]
39. Current concepts in malignant pleural mesothelioma.
Kaufman AJ; Pass HI
Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069
[TBL] [Abstract][Full Text] [Related]
40. Intrapleural perfusion hyperthermo-chemotherapy under video-assisted thoracoscopic surgery for malignant pleural dissemination: a case report.
Watanabe S; Sakasegawa K; Shimokawa S; Kariatsumari K; Nakamura Y; Sakata R
Anticancer Res; 2002; 22(6B):3781-3. PubMed ID: 12552992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
